FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382918966> ?p ?o ?g. }

• W4382918966 endingPage "3416" @default.
• W4382918966 startingPage "3405" @default.
• W4382918966 abstract "Chronic inflammation is considered the most critical predisposing factor of hepatocellular carcinoma (HCC), with inflammatory cell heterogeneity, hepatic fibrosis accumulation, and abnormal vascular proliferation as prominent features of the HCC tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) play a key role in HCC TME remodeling. Therefore, the level of abundance of CAFs may significantly affect the prognosis and outcome in HCC patients.Unsupervised clustering was performed based on 39 genes related to CAFs in HCC identified by single-cell RNA sequencing data. Patients of bulk RNA were grouped into CAF low abundance cluster and high abundance clusters. Subsequently, prognosis, immune infiltration landscape, metabolism, and treatment response between the two clusters were investigated and validated by immunohistochemistry.Patients in the CAF high cluster had a higher level of inflammatory cell infiltration, a more significant immunosuppressive microenvironment, and a significantly worse prognosis than those in the low cluster. At the metabolic level, the CAF high cluster had lower levels of aerobic oxidation and higher angiogenic scores. Drug treatment response prediction indicated that the CAF high cluster could have a better response to PD-1 inhibitors and conventional chemotherapeutic agents for HCC such as anti-angiogenic drugs, whereas CAF low cluster may be more sensitive to transarterial chemoembolization treatment.This study not only revealed the TME characteristics of HCC with the difference in CAF abundance but also further confirmed that the combination therapy of PD-1 inhibitors and anti-angiogenic drugs may be more valuable for patients with high CAF abundance." @default.
• W4382918966 created "2023-07-04" @default.
• W4382918966 creator A5007708850 @default.
• W4382918966 creator A5010507933 @default.
• W4382918966 creator A5019959190 @default.
• W4382918966 creator A5022525513 @default.
• W4382918966 creator A5035282947 @default.
• W4382918966 creator A5042339155 @default.
• W4382918966 creator A5048034673 @default.
• W4382918966 creator A5054563185 @default.
• W4382918966 creator A5062647351 @default.
• W4382918966 creator A5069811393 @default.
• W4382918966 creator A5074385560 @default.
• W4382918966 creator A5087303026 @default.
• W4382918966 date "2023-07-03" @default.
• W4382918966 modified "2023-10-17" @default.
• W4382918966 title "Cancer‐associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD‐1 inhibitors and antiangiogenic agents in hepatocellular carcinoma" @default.
• W4382918966 cites W1757407923 @default.
• W4382918966 cites W2032431248 @default.
• W4382918966 cites W2033998652 @default.
• W4382918966 cites W2048253455 @default.
• W4382918966 cites W2080453532 @default.
• W4382918966 cites W2168631000 @default.
• W4382918966 cites W2404457105 @default.
• W4382918966 cites W2512899508 @default.
• W4382918966 cites W2561981917 @default.
• W4382918966 cites W2590941489 @default.
• W4382918966 cites W2598230851 @default.
• W4382918966 cites W2890324251 @default.
• W4382918966 cites W2921558231 @default.
• W4382918966 cites W3009052374 @default.
• W4382918966 cites W3011816813 @default.
• W4382918966 cites W3081755994 @default.
• W4382918966 cites W3092240599 @default.
• W4382918966 cites W3119005666 @default.
• W4382918966 cites W3124426649 @default.
• W4382918966 cites W3126965123 @default.
• W4382918966 cites W3133981801 @default.
• W4382918966 cites W3157116981 @default.
• W4382918966 cites W3157710113 @default.
• W4382918966 cites W4221005724 @default.
• W4382918966 cites W4225263834 @default.
• W4382918966 cites W4281675839 @default.
• W4382918966 cites W4281752747 @default.
• W4382918966 cites W4296017867 @default.
• W4382918966 cites W4297986244 @default.
• W4382918966 cites W4310522789 @default.
• W4382918966 cites W4310753278 @default.
• W4382918966 cites W4315620179 @default.
• W4382918966 doi "https://doi.org/10.1002/cncr.34935" @default.
• W4382918966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37395148" @default.
• W4382918966 hasPublicationYear "2023" @default.
• W4382918966 type Work @default.
• W4382918966 citedByCount "1" @default.
• W4382918966 countsByYear W43829189662023 @default.
• W4382918966 crossrefType "journal-article" @default.
• W4382918966 hasAuthorship W4382918966A5007708850 @default.
• W4382918966 hasAuthorship W4382918966A5010507933 @default.
• W4382918966 hasAuthorship W4382918966A5019959190 @default.
• W4382918966 hasAuthorship W4382918966A5022525513 @default.
• W4382918966 hasAuthorship W4382918966A5035282947 @default.
• W4382918966 hasAuthorship W4382918966A5042339155 @default.
• W4382918966 hasAuthorship W4382918966A5048034673 @default.
• W4382918966 hasAuthorship W4382918966A5054563185 @default.
• W4382918966 hasAuthorship W4382918966A5062647351 @default.
• W4382918966 hasAuthorship W4382918966A5069811393 @default.
• W4382918966 hasAuthorship W4382918966A5074385560 @default.
• W4382918966 hasAuthorship W4382918966A5087303026 @default.
• W4382918966 hasConcept C121332964 @default.
• W4382918966 hasConcept C121608353 @default.
• W4382918966 hasConcept C126322002 @default.
• W4382918966 hasConcept C143998085 @default.
• W4382918966 hasConcept C1491633281 @default.
• W4382918966 hasConcept C153400128 @default.
• W4382918966 hasConcept C203014093 @default.
• W4382918966 hasConcept C2776107976 @default.
• W4382918966 hasConcept C2778019345 @default.
• W4382918966 hasConcept C2780559512 @default.
• W4382918966 hasConcept C502942594 @default.
• W4382918966 hasConcept C54355233 @default.
• W4382918966 hasConcept C71924100 @default.
• W4382918966 hasConcept C86803240 @default.
• W4382918966 hasConcept C8891405 @default.
• W4382918966 hasConcept C97355855 @default.
• W4382918966 hasConceptScore W4382918966C121332964 @default.
• W4382918966 hasConceptScore W4382918966C121608353 @default.
• W4382918966 hasConceptScore W4382918966C126322002 @default.
• W4382918966 hasConceptScore W4382918966C143998085 @default.
• W4382918966 hasConceptScore W4382918966C1491633281 @default.
• W4382918966 hasConceptScore W4382918966C153400128 @default.
• W4382918966 hasConceptScore W4382918966C203014093 @default.
• W4382918966 hasConceptScore W4382918966C2776107976 @default.
• W4382918966 hasConceptScore W4382918966C2778019345 @default.
• W4382918966 hasConceptScore W4382918966C2780559512 @default.
• W4382918966 hasConceptScore W4382918966C502942594 @default.
• W4382918966 hasConceptScore W4382918966C54355233 @default.
• W4382918966 hasConceptScore W4382918966C71924100 @default.
• W4382918966 hasConceptScore W4382918966C86803240 @default.

• next